Tenders/Part No. 1 - Guselkumabum
Awarded🇵🇱PolandSupplies

Part No. 1 - Guselkumabum

Auto-translated from Polish
Original title: Część nr 1 - Guselkumabum
Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie
Published: Oct 28, 2026
Updated: Oct 28, 2026
Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Polish
1. Various medicines: Guselkumabum concentrate for solution for infusion, 200 mg/20ml vial.; Guselkumabum solution for injection, 100 mg/1ml pre-filled syringe; Guselkumabum solution for injection in a pre-filled pen, 200 mg/2ml pen/pen. 2. A detailed description of the subject of the order and the Contracting Authority's requirements are specified in the Price-Offer Form – Annexes No. 1 for individual parts, which are an integral part of the SWZ. 3. The scope of the order includes the delivery of the subject of the order in the quantities specified in the Price-Offer Form for the period: Part No. 1 – for 12 months from the date of contract conclusion. 4. The Contracting Authority does not allow the submission of equivalent offers. 5. ORDER COMPLETION DEADLINE: 5.1 The subject of the order for Part No. 1 will be carried out in the form of successive deliveries for a period of 12 months from the date of contract conclusion. 5.2 In the event that the subject of the order for Part No. 1 is not fully completed during the contract period, the Contracting Authority reserves the right to extend the contract period. A change in the contract period will occur through a written annex signed by the Parties. The Contracting Authority will inform the Contractor of the intention to extend the contract period before its expiry.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 28, 2026. Last refreshed 21 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie

Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie has issued 135 procurement notices on BidsFactory, including 6 currently open and 50 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and General Supplies & Services. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU), Poland e-Zamówienia, and SmartPZP. Most recent publication: November 16, 2026.

Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie: buyer profile, tenders and awards

Frequently asked questions about this tender

Is this tender still open?

No — the contract has already been awarded to Janssen-Cilag Polska Spółka z ograniczoną odpowiedzialnością; URTICA Spółka z ograniczoną odpowiedzialnością; AstraZeneca Kft.; Takeda Pharma Spółka z ograniczoną odpowiedzialnością. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

Janssen-Cilag Polska Spółka z ograniczoną odpowiedzialnością; URTICA Spółka z ograniczoną odpowiedzialnością; AstraZeneca Kft.; Takeda Pharma Spółka z ograniczoną odpowiedzialnością was awarded the contract for €26,651,564. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Polish

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie
🇵🇱Poland